Osaic Holdings’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $30.4K | Sell |
1,053
-5,407
| -84% | -$156K | ﹤0.01% | 5038 |
|
2025
Q1 | $261K | Buy |
6,460
+5,352
| +483% | +$217K | ﹤0.01% | 3422 |
|
2024
Q4 | $30.8K | Buy |
1,108
+8
| +0.7% | +$223 | ﹤0.01% | 5024 |
|
2024
Q3 | $31.6K | Hold |
1,100
| – | – | ﹤0.01% | 5046 |
|
2024
Q2 | $25.8K | Sell |
1,100
-1,878
| -63% | -$44.1K | ﹤0.01% | 5125 |
|
2024
Q1 | $75.2K | Sell |
2,978
-421
| -12% | -$10.6K | ﹤0.01% | 4442 |
|
2023
Q4 | $79.4K | Sell |
3,399
-1,843
| -35% | -$43K | ﹤0.01% | 4583 |
|
2023
Q3 | $265K | Buy |
5,242
+3,433
| +190% | +$174K | ﹤0.01% | 3783 |
|
2023
Q2 | $84.5K | Buy |
1,809
+359
| +25% | +$16.8K | ﹤0.01% | 4561 |
|
2023
Q1 | $55.5K | Buy |
1,450
+315
| +28% | +$12.1K | ﹤0.01% | 4869 |
|
2022
Q4 | $62K | Sell |
1,135
-289
| -20% | -$15.8K | ﹤0.01% | 4771 |
|
2022
Q3 | $48K | Buy |
1,424
+1,150
| +420% | +$38.8K | ﹤0.01% | 4920 |
|
2022
Q2 | $3K | Hold |
274
| – | – | ﹤0.01% | 6638 |
|
2022
Q1 | $4K | Sell |
274
-723
| -73% | -$10.6K | ﹤0.01% | 6476 |
|
2021
Q4 | $22K | Buy |
997
+112
| +13% | +$2.47K | ﹤0.01% | 5693 |
|
2021
Q3 | $19K | Hold |
885
| – | – | ﹤0.01% | 5789 |
|
2021
Q2 | $22K | Sell |
885
-400
| -31% | -$9.94K | ﹤0.01% | 5579 |
|
2021
Q1 | $37K | Buy |
+1,285
| New | +$37K | ﹤0.01% | 5057 |
|